Dana-Farber Cancer Institute

Centers for Early Detection and Interception

    In this section

    When we can detect cancer early, we have a greater chance of treating and curing that cancer.

    That’s why we created the Centers for Early Detection and Interception. Specifically for individuals who have an increased risk of developing cancer, this integrated clinical and research program aims to detect cancer sooner and stop pre-cancerous conditions from progressing.

    Several factors impact someone’s likelihood of developing cancer in their lifetime:

    • Genetic conditions, such as Lynch syndrome or BRCA genes
    • Precursor conditions, such as smoldering myeloma, clonal hematopoiesis, or Barrett’s esophagus. These conditions are all early phases of diseases that may develop into cancers.
    • Positive result from a multi-cancer early detection test, like the Galleri test from GRAIL
    • Family history of cancer
    • Previous cancer

    If any of these risk factors apply to you — or your patient — contact us.

    Request an Appointment or Referral

    617-762-2334

    Dana-Farber’s Centers for Early Detection and Interception is a new multidisciplinary clinical and research program for individuals who are at increased risk of developing cancer.

    Talk with one of our experts to evaluate if the Centers for Early Detection and Interception is the right next step for you or your patient's care.

    Multidisciplinary Care, Centered Around You

    We understand our patients may have one or a combination of risk factors for cancer. Our specialized care teams can help you understand and reduce your individual risk of progressing to cancer. Starting with an initial diagnostic evaluation, you'll receive a personalized plan for monitoring and interventions.

    Depending on your risk factors, you may be seen by a combination of experts from our Centers for Early Detection and Interception specialty programs. These clinical and research centers focus on precursor and hereditary conditions that can be early indicators of blood cancers and solid tumors.

    About Our Vision to Transform Cancer Care

    Specialty Centers and Clinics

    Blood Cancers

    The Center for Early Detection and Interception of Blood Cancers helps patients manage precursor conditions of hematologic malignancies that can lead to blood cancers such as chronic lymphocytic leukemia, lymphoma, and multiple myeloma.

    Multi-Cancer Early Detection Clinic

    Using a single blood sample, multi-cancer early detection (MCED) tests screen for numerous types of cancers, including breast, cervical, colorectal, and prostate cancers. Our clinic provides comprehensive diagnostic evaluations for patients with a positive MCED test.

    Genetic Testing, Hereditary Conditions and Syndromes

    Lynch Syndrome Center

    Lynch syndrome is a common and often under-diagnosed inherited condition that increases one's risk for a variety of cancers, including colon, rectal, uterine, ovarian, urinary tract, and other malignancies. The Lynch Syndrome Center provides comprehensive care for patients with Lynch syndrome including prevention trials of vaccines, studies of risk-reducing strategies and studies of novel early detection markers.

    Li-Fraumeni Syndrome and TP53 Center

    The Li-Fraumeni Syndrome and TP53 Center specializes in caring for people with diagnoses of LFS and with TP53+, or those who have a family history of Li-Fraumeni syndrome.

    Center for BRCA and Related Genes

    Mutations in BRCA1, BRCA2, and BRCA-related genes confer increased risk of certain cancers when inherited. These mutations can also be acquired by the cancers themselves. The Mellen and Eisenson Family Center for BRCA and Related Genes provides comprehensive care for patients with inherited and acquired mutations, including clinical therapeutic trials, trials of risk-reducing strategies, and studies of novel early detection markers.

    More About Cancer Early Detection and Interception